Elizabeth Raveché

3.6k citations
83 papers · 2.8k indexed · h-index 31

Elizabeth Raveché

82 papers receiving 2.7k citations

Peers

Elizabeth Raveché
Comparison fields: 5 of 100
  • Immunology 1.6k
  • Genetics 580
  • Cancer Research 465
  • Rheumatology 368
  • Pathology and Forensic Medicine 349
Replace Roberta Pelanda with:
Roberta Pelanda United States
Susan A. Shinton United States
Alec M. Cheng United States
Ruth I. Brezinschek United States
Horst Dürkop Germany
Laura S. Grosmaire United States
J F Daley United States
L M Nadler United States
Elizabeth E. Brown United States
Miriam A. Shelef United States
Elizabeth Raveché relative to Roberta Pelanda United States Roberta Pelanda's profile →
Citations per field
00.5×1.5×2.4×
Roberta Pelanda · 1×
Citations per year

Countries citing papers authored by Elizabeth Raveché

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Raveché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Raveché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Raveché more than expected).

Fields of papers citing papers by Elizabeth Raveché

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Raveché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Raveché. The network helps show where Elizabeth Raveché may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elizabeth Raveché, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Raveché Line = papers co-authored together Elizabeth Raveché links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20146
2 201237
3 201159
4 200958
5 200750
6 200445
7 20001
8 19993
9 19985
10 19988
11 1997141
12 19959
13 199534
14 19923
15 19926
16 19921
17 199054
18 198730
19 197934
20 197879

About Elizabeth Raveché

Elizabeth Raveché is a scholar working on Genetics, Immunology and Hematology, having authored 83 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (31 papers), Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (23 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Lymphoma Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (9 papers), Galectins and Cancer Biology (9 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Immunology (1.6k citations), Genetics (580 citations) and Cancer Research (465 citations). Elizabeth Raveché has collaborated with scholars based in United States, Poland and United Kingdom. Frequent co-authors include A D Steinberg, J. H. Tjio, Alfred D. Steinberg, W E Paul, Anthony DeFranco, Richard Asofsky, Gerald E. Marti, Helen Fernandes, Sergei V. Kotenko and Erica Salerno. Their work appears in journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026